These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 19054553

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Melatonin receptor agonist].
    Uchiyama M.
    Nihon Rinsho; 2015 Jun; 73(6):1017-22. PubMed ID: 26065135
    [Abstract] [Full Text] [Related]

  • 3. Ramelteon: a melatonin receptor agonist for the treatment of insomnia.
    Devi V, Shankar PK.
    J Postgrad Med; 2008 Jun; 54(1):45-8. PubMed ID: 18296808
    [Abstract] [Full Text] [Related]

  • 4. [Preclinical pharmacological profiles and clinical outcome of the novel melatonin-receptor agonist ramelteon (Rozerem 8 mg).].
    Hirai K, Kato K, Nishikawa H, Yukuhiro N, Nishiyama K, Miyamoto M.
    Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):51-60. PubMed ID: 20628215
    [No Abstract] [Full Text] [Related]

  • 5. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
    Pandi-Perumal SR, Srinivasan V, Poeggeler B, Hardeland R, Cardinali DP.
    Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
    [Abstract] [Full Text] [Related]

  • 6. Ramelteon: new drug. Insomnia: no role for risky placebos.
    Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
    [Abstract] [Full Text] [Related]

  • 7. Augmentation with ramelteon to achieve remission in geriatric major depression.
    Furuya M, Kunishige K, Miyaoka T, Wake R, Liaury K, Sadakuni F, Horiguchi J.
    Psychiatry Clin Neurosci; 2012 Feb; 66(1):81-2. PubMed ID: 22250616
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fresh from the pipeline: Ramelteon.
    Buysse D, Bate G, Kirkpatrick P.
    Nat Rev Drug Discov; 2005 Nov; 4(11):881-2. PubMed ID: 16299918
    [No Abstract] [Full Text] [Related]

  • 10. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP.
    Int J Neurosci; 2009 Nov; 119(6):821-46. PubMed ID: 19326288
    [Abstract] [Full Text] [Related]

  • 11. Night-to-night variability of sleep latency significantly predicts the magnitude of subsequent change in sleep latency during placebo administration.
    Ogawa A, Hinotsu S, Urushihara H, Kawakami K.
    Sleep Med; 2011 Jun; 12(6):565-71. PubMed ID: 21570345
    [Abstract] [Full Text] [Related]

  • 12. Searching for new options for treating insomnia: are melatonin and ramelteon beneficial?
    Bellon A.
    J Psychiatr Pract; 2006 Jul; 12(4):229-43. PubMed ID: 16883148
    [Abstract] [Full Text] [Related]

  • 13. Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis.
    Kuriyama A, Honda M, Hayashino Y.
    Sleep Med; 2014 Apr; 15(4):385-92. PubMed ID: 24656909
    [Abstract] [Full Text] [Related]

  • 14. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R.
    Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
    [Abstract] [Full Text] [Related]

  • 15. Ramelteon (rozerem) a novel approach for insomnia treatment.
    Laustsen G, Andersen M.
    Nurse Pract; 2006 Apr; 31(4):52-5. PubMed ID: 16607213
    [No Abstract] [Full Text] [Related]

  • 16. Intrinsic circadian period of sighted patients with circadian rhythm sleep disorder, free-running type.
    Kitamura S, Hida A, Enomoto M, Watanabe M, Katayose Y, Nozaki K, Aritake S, Higuchi S, Moriguchi Y, Kamei Y, Mishima K.
    Biol Psychiatry; 2013 Jan 01; 73(1):63-9. PubMed ID: 22846439
    [Abstract] [Full Text] [Related]

  • 17. Melatonin and its receptors: a new class of sleep-promoting agents.
    Doghramji K.
    J Clin Sleep Med; 2007 Aug 15; 3(5 Suppl):S17-23. PubMed ID: 17824497
    [No Abstract] [Full Text] [Related]

  • 18. [A nationwide survey on the uses of melatonin and ramelteon in Japanese children].
    Fukumizu M, Hayashi M, Miyajima T, Ishizaki A, Tanaka H, Kohyama J.
    No To Hattatsu; 2015 Jan 15; 47(1):23-7. PubMed ID: 25803907
    [Abstract] [Full Text] [Related]

  • 19. Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder.
    Johnsa JD, Neville MW.
    Ann Pharmacother; 2014 Dec 15; 48(12):1636-41. PubMed ID: 25204464
    [Abstract] [Full Text] [Related]

  • 20. Investigational melatonin receptor agonists.
    Hardeland R.
    Expert Opin Investig Drugs; 2010 Jun 15; 19(6):747-64. PubMed ID: 20408738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.